These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Kang JY; Tay HH; Wee A; Guan R; Math MV; Yap I Gut; 1990 Apr; 31(4):476-80. PubMed ID: 2186982 [TBL] [Abstract][Full Text] [Related]
24. The protective roles of some lichen species on colloidal bismuth subcitrate genotoxicity. Geyikoglu F; Turkez H; Aslan A Toxicol Ind Health; 2007 Sep; 23(8):487-92. PubMed ID: 18669170 [TBL] [Abstract][Full Text] [Related]
25. Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate. Stiel D; Murray DJ; Peters TJ Gut; 1985 Apr; 26(4):364-8. PubMed ID: 3979909 [TBL] [Abstract][Full Text] [Related]
27. Case 1: Mysteriously Rising Salicylate Levels in a 15-year-old Girl. Parker V; Goldberg D; King MA Pediatr Rev; 2017 Jun; 38(6):280-281. PubMed ID: 28572137 [No Abstract] [Full Text] [Related]
28. Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat. Hinsull SM Gut; 1991 Apr; 32(4):355-60. PubMed ID: 2026333 [TBL] [Abstract][Full Text] [Related]
29. Six cases of poisoning after a parenteral organic mercurial compound (Merthiolate). Axton JH Postgrad Med J; 1972 Jul; 48(561):417-21. PubMed ID: 5069897 [TBL] [Abstract][Full Text] [Related]
30. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial. Wilson P; Alp MH Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603 [TBL] [Abstract][Full Text] [Related]
31. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa. Balint GA Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857 [TBL] [Abstract][Full Text] [Related]
32. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023 [TBL] [Abstract][Full Text] [Related]
33. A scanning electron microscopic morphological and semi-quantitative evaluation of rat stomach treated with colloidal bismuth subcitrate and alcohol. Winters C; Hinsull SM; Gregory Z Scanning Microsc; 1991 Jun; 5(2):541-7; discussion 547-8. PubMed ID: 1947936 [TBL] [Abstract][Full Text] [Related]
34. Effect of repeated colloidal bismuth subcitrate treatment on the response of the rat gastric mucosa to the presence of luminal ethanol. Hinsull SM; Bellamy D Gut; 1990 Apr; 31(4):389-96. PubMed ID: 2338263 [TBL] [Abstract][Full Text] [Related]
35. [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate]. Zhang L; Zhang ST; Yu ZL; Shao Y Zhonghua Nei Ke Za Zhi; 2005 Apr; 44(4):272-5. PubMed ID: 15924641 [TBL] [Abstract][Full Text] [Related]
36. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid. Lee SP Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540 [TBL] [Abstract][Full Text] [Related]
37. Colloidal bismuth subcitrate in non-ulcer dyspepsia. Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406 [TBL] [Abstract][Full Text] [Related]
39. Determination of trimethylbismuth in the human body after ingestion of colloidal bismuth subcitrate. Boertz J; Hartmann LM; Sulkowski M; Hippler J; Mosel F; Diaz-Bone RA; Michalke K; Rettenmeier AW; Hirner AV Drug Metab Dispos; 2009 Feb; 37(2):352-8. PubMed ID: 18981168 [TBL] [Abstract][Full Text] [Related]